(Q40303273)

English

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies

scientific article published on 19 July 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies (English)

1 reference

Europe PubMed Central

19 September 2017

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Zannad F

1

1 reference

Europe PubMed Central

19 September 2017

Kessler M

2

1 reference

Europe PubMed Central

19 September 2017

Lehert P

3

1 reference

Europe PubMed Central

19 September 2017

Grünfeld JP

4

1 reference

Europe PubMed Central

19 September 2017

Thuilliez C

5

1 reference

Europe PubMed Central

19 September 2017

Leizorovicz A

6

1 reference

Europe PubMed Central

19 September 2017

Lechat P

7

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

19 July 2006

1 reference

Europe PubMed Central

19 September 2017

Kidney International

1 reference

Europe PubMed Central

19 September 2017

70

1 reference

Europe PubMed Central

19 September 2017

7

1 reference

Europe PubMed Central

19 September 2017

1318-1324

1 reference

Europe PubMed Central

19 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.ki.5001657

0 references

Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative mortality from cardiovascular disease in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myocardial infarction and renal dysfunction: a high-risk combination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the M

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Representation of the elderly, women, and minorities in heart failure clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

ACE inhibitors and survival of hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the Steady-State Pharmacokinetics of Fosinopril, Lisinopril and Enalapril in Patients with Chronic Renal Insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

On model prespecification in confirmatory randomized studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001657

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.KI.5001657

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40303273&oldid=1894213792"